Drugs Made In America Acquisition Corp. Units (DMAAU)
DMAAU Stock Price Chart
Explore Drugs Made In America Acquisition Corp. Units interactive price chart. Choose custom timeframes to analyze DMAAU price movements and trends.
DMAAU Company Profile
Discover essential business fundamentals and corporate details for Drugs Made In America Acquisition Corp. Units (DMAAU) to support your stock research and investment decisions.
Sector
Financial Services
Industry
Financial - Conglomerates
IPO Date
27 Jan 2025
Employees
2.00
Website
https://dmaacorp.comCEO
Lynn Stockwell
Description
Drugs Made In America Acquisition Corp. is a blank check company. It is an exempt company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.
DMAAU Financial Timeline
Browse a chronological timeline of Drugs Made In America Acquisition Corp. Units corporate events including earnings releases, dividend announcements, and stock splits.
DMAAU Stock Performance
Access detailed DMAAU performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.